Georgette Charles | Future Pharma

Future Pharma 2026

June 1 - 2, 2026

Renaissance Seaport District, Boston, MA

Georgette Charles

Georgette Charles

Former Director of Market Insights & Intelligence UCB

Redefining Engagement: Trust, Technology, and Transformation

9:40 AM Keynote: From Monitoring to Market Shaping: The Next Evolution of Competitive Intelligence in Pharma

Competitive intelligence is moving beyond retrospective tracking of pipelines and promotional activity toward a more predictive, action-oriented role in commercial strategy. As digital engagement, real-world data, and AI expand the volume and velocity of market signals, leading pharma organizations are redefining CI as a catalyst for sharper brand positioning, stronger launch execution, and faster strategic decision-making.

This session will highlight practical approaches to elevating CI from a reporting function to a market-shaping capability - enabling teams to anticipate competitor moves, influence cross-functional priorities, and accelerate insight-to-impact across the product lifecycle. 

  • Translating competitive signals into clear commercial actions that inform brand, launch, and engagement strategy.
  • Applying predictive analytics and scenario planning to guide proactive market positioning.
  • Embedding intelligence into commercial, medical, and market access planning rhythms.
  • Using agile processes and executive-ready storytelling to drive faster, aligned decisions. 

Check out the incredible speaker line-up to see who will be joining Georgette.

Download The Latest Agenda